Approval of the protocol for the post-approval study (pas) referenced above. The pas protocol has been submitted to comply with the conditions of approval outlined in our approval order for p150026/s008.
Device | HeartLight Catheter and HeartLight Console |
Generic Name | Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation |
Applicant | CARDIOFOCUS, INC. |
Date Received | 2020-06-01 |
Decision Date | 2020-07-01 |
PMA | P150026 |
Supplement | S011 |
Product Code | OAE |
Advisory Committee | Cardiovascular |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol - Ode/oir |
Expedited Review | No |
Combination Product | No |
Applicant Address | CARDIOFOCUS, INC. 500 Nickerson Road marlborough, MA 01752 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P150026 | | Original Filing |
S013 |
2022-03-04 |
Normal 180 Day Track |
S012 |
2021-01-06 |
Normal 180 Day Track |
S011 |
2020-06-01 |
Normal 180 Day Track No User Fee |
S010 |
2020-01-22 |
30-day Notice |
S009 |
2019-12-18 |
30-day Notice |
S008 | | |
S007 |
2019-08-13 |
Real-time Process |
S006 |
2019-05-29 |
Special (immediate Track) |
S005 |
2019-01-08 |
Normal 180 Day Track |
S004 |
2018-04-04 |
30-day Notice |
S003 |
2017-11-09 |
Real-time Process |
S002 |
2017-08-09 |
Normal 180 Day Track |
S001 |
2017-05-05 |
Real-time Process |
NIH GUDID Devices